OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
SPEAKER BIOGRAPHY
I practice in a busy cardiothoracic and transplant center in the OR and ICU and Chair the Transfusion Committee at the affiliated Durham VA Hospital. My research is focused on my interest in thrombosis, bleeding, transfusion and anticoagulation, which is closely related to an extended commitment to understanding perioperative coagulation, coagulopathy, anticoagulation, transfusion and associated adverse outcomes.
In terms of grant support, as the Duke site PI for the Rare Thrombotic Diseases Clinical Research Network (NIH U54 HL77878; PI Dr T Ortel), patients were enrolled for this prospective, observational cohort study that evaluated the anti-heparin/platelet factor 4 antibodies, that commonly develop after cardiac surgery, as an independent risk factor for early and late thromboembolic complications.
Avoiding transfusion is desirable but, if necessary, transfusing the optimal product is essential. I completed funding to study Point of Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications (NIH R01HL121232-01; Mayo Clinic and overall PI Dr DJ Kor, co-PIO/Duke PI Dr IJ Welsby) and have been the Duke PI for RECIPI a BARDA funded multicenter study of pathogen reduced red blood cells in cardiac surgery.
On-going interests include manipulating the oxygen affinity of hemoglobin to optimize oxygen delivery and the use of clotting factor concentrates to reverse perioperative coagulopathy.
